TrialsgrambetaRCTs are beautiful

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease

This guideline cites 5 of the 199 landmark trials in our Cardiology register.

The 2022 guideline is the first ACC/AHA document to treat the aorta as one organ from root to bifurcation, and it is more surgical in temperament than the aortic chapters of the ESC's 2024 peripheral and aortic guideline. Its signature moves are the lowering of the elective repair threshold for ascending aneurysms to 5.0 cm in experienced multidisciplinary aortic centres (with earlier surgery for heritable aortopathy or aortic-size index criteria), the systematic use of genetic testing and family screening in heritable thoracic aortic disease, and shared decision-making around pregnancy. Where randomised evidence exists it is largely in the abdominal aorta and in type B dissection — those trials are grouped below.

Abdominal aortic aneurysm: repair thresholds & surveillance2

  • 2016EVAR-1⁠Cardiology · Vascular · Aortic aneurysmIn 1,252 patients with a large asymptomatic abdominal aortic aneurysm fit for either procedure, endovascular aneurysm repair gave an early survival benefit but inferior late all-cause and aneurysm-related mortality compared with open surgical repair.HR 1.1195% CI 0.97-1.27Read →
  • 1998UK Small Aneurysm Trial Core⁠Cardiology · Vascular · Aortic aneurysmIn 1,090 patients aged 60–76 years with a symptomless abdominal aortic aneurysm of 4.0–5.5 cm, early elective open repair did not reduce long-term all-cause mortality compared with ultrasonographic surveillance.HR 0.9495% CI 0.75-1.17Read →

Ruptured abdominal aortic aneurysm: endovascular vs. open1

  • 2014IMPROVE⁠Cardiology · Vascular · Aortic aneurysmIn 613 patients with a clinical diagnosis of ruptured abdominal aortic aneurysm, an endovascular-first strategy did not reduce 30-day mortality compared with emergency open repair.OR 0.9295% CI 0.66-1.28Read →

Type B aortic dissection1

  • 2013INSTEAD-XL⁠Cardiology · Vascular · Aortic dissectionIn 140 patients with stable uncomplicated type B aortic dissection, thoracic endovascular aortic repair added to optimal medical therapy reduced 5-year aorta-specific mortality and disease progression compared with optimal medical therapy alone.Read →

Medical therapy: blood-pressure control1

  • 2015SPRINT Core⁠Cardiology · HTN · BP targetIn 9,361 high-risk non-diabetic hypertensive adults, intensive BP control to SBP < 120 mm Hg reduced CV events and all-cause mortality compared with standard control to SBP < 140 mm Hg.HR 0.75Read →

Cited landmark trials not yet in the register5

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

  • 2002ADAM

    Immediate repair versus surveillance of small abdominal aortic aneurysms — the US counterpart to the UK Small Aneurysm Trial.

  • 2004DREAM

    Endovascular versus open repair of abdominal aortic aneurysm.

  • 2009OVER

    The US Veterans Affairs trial of endovascular versus open AAA repair — an early survival advantage that faded.

  • 1998IRAD

    The International Registry of Acute Aortic Dissection — the observational backbone of acute aortic syndrome management.

  • 2013COMPARE / LOAT

    Losartan in Marfan syndrome — the randomised basis for angiotensin-receptor blockade in heritable aortopathy.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.